Click Here to return To Results

 

Evaluation of CSf-tau and CSF-AB42 as Diagnostic Markers for Alzheimer Disease in Clinical Practice Arch Neurol 58:373-379,349, Andreasen,N.,et al, 2001 See this aricle in Pubmed Article Abstract Cerebrospinal fluid tau and CSF-A(42 have so far been studied in research settings under conditions providing data on the optimal performance. WE examined a prospective patients sample, with assays run in clinical routine giving figures clo ser to the true performance of CSF-tau and CSF-A(42. The predictive value for AD was greater than 90%. Therefore, these biomarkers may have a role in the clinical workup of patients with cognitive impairment, especially to differentiate early AD from no rmal aging and psychiatric disorders.

Related Tags

(click to filter results - removes previous filter) Alzheimer's disease Alzheimer's disease,diagnosis of amyloid amyloid beta protein cerebrospinal fluid cerebrospinal fluid,abnormal dementia,diagnostic evaluation of neurologic disease,diagnoses of tau protein

Click Here to return To Results